Adrian von Segesser
Direttore/Membro del Consiglio presso ewl Energie Wasser Luzern Holding AG
Profilo
Adrian von Segesser has worked as a Director at SpePharm AG and as a Member-Supervisory Board at ewl Energie Wasser Luzern Holding AG.
Posizioni attive di Adrian von Segesser
| Società | Posizione | Inizio |
|---|---|---|
ewl Energie Wasser Luzern Holding AG
 ewl Energie Wasser Luzern Holding AG Alternative Power GenerationUtilities ewl Energie Wasser Luzern Holding AG engages in the generation and distribution of electricity. The firm’s services include electricity, gas, water, heat, telecommunications, and mobility. It also provides installation and energy consulting. The company was founded on December 18, 2000 and is headquartered in Lucerne, Switzerland. | Direttore/Membro del Consiglio | 01/01/2010 |
SpePharm AG
 SpePharm AG Pharmaceuticals: MajorHealth Technology SpePharm AG acquires, registers, and markets medical value medicines for the hospital sector. Its brands include Dantrium IV, Dantrium, Dantamacrin, Lymphoseek and Mugard. The company was founded in 2012 and is headquartered in Luzern, Switzerland. | Direttore/Membro del Consiglio | - |
Esperienze
Posizioni ricoperte
Attive
Inattive
Società quotate in Borsa
Aziende private
Relazioni
Relazioni di 1° grado
Aziende connesse in 1º grado
Uomo
Donna
Amministratori
Dirigenti
Società collegate
| Aziende private | 2 |
|---|---|
ewl Energie Wasser Luzern Holding AG
ewl Energie Wasser Luzern Holding AG Alternative Power GenerationUtilities ewl Energie Wasser Luzern Holding AG engages in the generation and distribution of electricity. The firm’s services include electricity, gas, water, heat, telecommunications, and mobility. It also provides installation and energy consulting. The company was founded on December 18, 2000 and is headquartered in Lucerne, Switzerland. | Utilities |
SpePharm AG
SpePharm AG Pharmaceuticals: MajorHealth Technology SpePharm AG acquires, registers, and markets medical value medicines for the hospital sector. Its brands include Dantrium IV, Dantrium, Dantamacrin, Lymphoseek and Mugard. The company was founded in 2012 and is headquartered in Luzern, Switzerland. | Health Technology |
- Borsa valori
- Insiders
- Adrian von Segesser
